The FDA has reportedly proposed stricter emergency authorization standards, which are now under review by the White House Office of Management and Budget.

“That has to be approved by the White House,” Trump said of the FDA guidance. “We may or may not approve it.”

Trump also suggested that the FDA’s decision to pursue stricter standards “was a political move more than anything else.”